ADVIA CENTAUR XP TESTOSTERONE ASSAY N/A 10309989

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-03-16 for ADVIA CENTAUR XP TESTOSTERONE ASSAY N/A 10309989 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[40528519] The cause for the discordant advia centaur xp testosterone results during the lot to lot correlation study is unknown. Siemens healthcare diagnostics is investigating. The instrument is performing within specifications. The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[40528520] Discordant advia centaur xp testosterone results were obtained on samples from several patients during a lot to lot correlation study for reagent lots 181 and 200 with calibrator lot ce44. One sample showed a >30% difference between reagent lot 181 and lot 200. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant advia centaur xp testosterone result.
Patient Sequence No: 1, Text Type: D, B5


[42397078] On 03/27/2016 additional information: siemens has reviewed best practices for performing a successful lot to lot correlation study with the customer. Siemens recommended using fresh materials and new calibrations for both lots. Ideally using the same calibrator lot. The samples should be run on both lots as close as possible to the same time. Testosterone samples must be only stored at room temp for 8 hours and 2-8c for 48 hours for stability. Due to the stability requirements it is recommended that the study be performed on same day. The sample selection can make an impact on the study. The samples used should have concentrations which cover the entire measurement range of the assay. The customer is satisfied with reagent lot 200 and will continue testing with the advia centaur xp testosterone assay. The instrument is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1219913-2016-00055
MDR Report Key5506142
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-03-16
Date of Report2016-02-24
Date of Event2016-02-24
Date Mfgr Received2016-03-27
Device Manufacturer Date2015-09-22
Date Added to Maude2016-03-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityWALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionIN
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP TESTOSTERONE ASSAY
Generic NameTESTOSTERONE IMMUNOASSAY
Product CodeCDZ
Date Received2016-03-16
Model NumberN/A
Catalog Number10309989
Lot Number200
Device Expiration Date2016-11-22
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.